GLP-1 Cost: What You Actually Pay in 2026

Ask what a GLP-1 costs and you get a number. The number is almost always real and almost always incomplete, because every advertised GLP-1 price in 2026 is a conditional offer, and the conditions do more work than the figure does.

What follows was read off the manufacturers’ own terms pages on 24 August 2026. Treat the structure as durable and the numbers as perishable.

What does a GLP-1 actually cost per month?

There are four different prices for the same drug, depending on which door you come through: commercial insurance that covers it, commercial insurance that does not, manufacturer self-pay, and the compounded market.

Route	Zepbound (tirzepatide)	Wegovy (semaglutide)
Commercial insurance, covered	as little as $25/month, capped	varies by plan
Self-pay, offer price	$449/month, 7.5–15 mg	$199/month, first 2 months
Self-pay, standard price	$299 (2.5 mg), $399 (5 mg), $499 (7.5 mg), $699 (10–15 mg)	$349/month, $399 for HD 7.2 mg
Oral	—	$149/month, 1.5 and 4 mg

Read the rows against each other and the pattern appears: the attractive number sits in the middle row, and the middle row is the one with strings on it.

What are the conditions?

The 45-day refill window. Lilly’s Self Pay Journey Program applies the $449 price to the 7.5, 10, 12.5, and 15 mg doses — but only if “you must complete your refill purchase … within 45 days of the delivery/received date of your previous” prescription. Miss it and, in Lilly’s words, “purchase offer will not apply” and the regular price returns: $499 at 7.5 mg and $699 at 10, 12.5, and 15 mg.

That is a swing of $250 a month triggered by a late refill. A delayed shipment, a holiday, a prescription that needs renewing — any of these can cost more than the dose escalation did.

New-patient limits and expiry dates. Novo’s $199 injectable Wegovy price is described as a limited-time offer covering a new patient’s first two months, stated as effective through 31 December 2026, after which the page lists $349 per month for standard strengths and $399 for Wegovy HD 7.2 mg. The oral tablet at $149 carries its own date: the 4 mg offering is listed as expiring 31 August 2026, moving to $199.

The annual cap on the insurance card. The commercial savings card advertises as little as $25 for a monthly fill, but savings are capped at $100 per one-month fill and, separately, at $1,300 per calendar year. At $100 of savings per month the cap is exhausted in thirteen fills, so the $25 figure describes part of a year, not a year.

None of this is hidden — it is in the published terms. But the number that reaches a patient is the headline, and the number that reaches their bank account is the headline plus the conditions. Those are different numbers.

Why is the list price so much higher?

List prices in this category run roughly $1,000–$1,350 a month and almost nobody pays them. The list price is the starting point for rebate negotiation with pharmacy benefit managers, not a retail price, which is why manufacturer direct-pay channels can quote a third of it without anything unusual happening.

This is also why “the price is coming down” is a slippery claim. A lower cash price and a lower net price are not the same event, and the arrival of genuine competition is a separate question again — covered in generic GLP-1s: when will prices fall?.

Is the pill cheaper than the injection?

At the moment, for semaglutide, yes: the oral Wegovy tablet is listed at $149 a month against $199 for the injectable starter price and $349 standard. That gap is a pricing decision, not a manufacturing fact, and it is as revisable as any other line on these pages. The clinical comparison between the oral and injectable options is a separate question, covered in GLP-1 pills: oral semaglutide and orforglipron.

Frequently asked questions

How much does a GLP-1 cost per month without insurance?

As of 24 August 2026, manufacturer self-pay pricing runs from $149 a month for oral Wegovy to $699 a month for higher-dose Zepbound outside its refill-window offer. The commonly quoted figures — $199, $349, $449 — each attach to specific doses and conditions rather than to the drug generally.

Why did my GLP-1 price go up?

The most common reasons are structural rather than personal: a refill completed outside a 45-day window, the end of a new-patient introductory period, a dated offer expiring, or an annual savings cap being reached. Each is written into the program terms.

Is compounded semaglutide cheaper?

It is often priced lower, and it is a different product category with different quality and legal considerations — not an FDA-approved product. The trade-offs are covered in compounded semaglutide: the risks and realities.

Does insurance cover GLP-1s for weight loss?

Coverage for the obesity indication is far less consistent than for type 2 diabetes, and it moves year to year. See GLP-1s and insurance coverage.

Which GLP-1 is cheapest?

On self-pay pricing at the time of writing, oral Wegovy at $149 a month is the lowest listed figure. “Cheapest” and “most appropriate” are different questions, and only the second one belongs to a prescriber.

The takeaway

The honest answer to “what does a GLP-1 cost” is that it depends on four things: which drug, which dose, which payment route, and whether you satisfy the conditions attached to the offer you were quoted.

The conditions are the part worth reading closely, because they are where a $449 month quietly becomes a $699 month. Before committing to a plan, read the specific program’s terms rather than a summary of them — including this one. Pricing in this category changes faster than anything else about these drugs, and the manufacturer pages linked below are the source of record.

GLP-1 Cost: What You Actually Pay, and the Conditions Attached